Amarin Corp Plcuk

AMRN

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0000897448

SEC filings (opens in a new tab)

No open-market purchases or sales by Amarin Corp Plcuk insiders were filed in the last 90 days; 81 institutions reported holding it in 13F filings for Q2 2026, worth $73.4M in total; no superinvestor holds it.

Key figures

Market capNo recent share count in SEC filings: –
Insider buysOpen market, last 90 days: 0
Insider sellsOpen market, last 90 days: 0
13F holdersQ2 2026, +12 vs. previous quarter: 81
13F valueReported value at the end of Q2 2026: $73.4M
Superinvestors holdingAt the end of Q2 2026: 0

Price chart

Chart by TradingView (opens in a new tab)

Financials

See financial statements

From SEC filings, in USD.

Revenue, FY2025: $213.6M; −6.5% year over year
Net income, FY2025: -$38.8M; No comparable prior period
Free cash flow, FY2025: –; No comparable prior period
Revenue, Q3 FY2026: $39.5M; −20.4% year over year

Revenue flow, FY2025

Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.

Net loss for FY2025: $38.8M (18.2% of revenue).

Short interest

See short data

From FINRA, settlement date Oct 30, 2026.

Short interest: 537.9K; Shares sold short
Change: +5.21K; +1.0% vs. previous
Days to cover: 7.58; At average daily volume

Superinvestors holding AMRN, Q2 2026

Go to the superinvestors tab

No superinvestor reported holding AMRN at the end of Q2 2026.

Latest insider trades

See all insider trades

Open-market purchases and sales by Amarin Corp Plcuk insiders from Form 4, newest first.

Insider trades
Filed (ET)	Trade date	Filing delay	Insider	Transaction	Shares	Avg price	Value	Holding change	Flags
Aug 5, 2024 (view filing)	Aug 2	3 days	Berg AaronPresident and CEO	PPurchase	+160.0K	$0.64	+$102.4K	+24.8%805.4K after
Jan 24, 2024 (view filing)	Jan 22	2 days	Holt PatrickPresident and CEO	PPurchase	+14.4K	$1.09	+$15.7K	+4.8%314.4K after
Dec 14, 2023 (view filing)	Dec 12	2 days	Ketchum Steven BChief Scientific Officer	SSale	−34.1K	$0.79	−$27.0K	−5.7%566.1K after	10b5-1
Aug 16, 2023 (view filing)	Aug 16	Same day	Holt PatrickPresident and CEO	PPurchase	+300.0K	$1.04	+$312.5K	New position300.0K after	7 lots
Jun 15, 2022 (view filing)	Jun 13	2 days	Wold Olsen PerDirector	PPurchase	+55.0K	$1.69	+$93.0K	+58.5%149.0K after
Dec 16, 2021 (view filing)	Dec 14-15	2 days	Zakrzewski Joseph SDirector	PPurchase	+12.0K	$3.25	+$39.0K	+6.5%196.5K after	2 lots
Aug 13, 2021 (view filing)	Aug 12	1 day	Kalb Michael WayneSVP and CFO	SSale	−120.0K	$5.25	−$630.0K	−36.9%205.0K after

Top 10 13F holders, Q2 2026

See all 81 holders

The largest institutional positions in Amarin Corp Plcuk at the end of Q2 2026; share changes are against Q1 2026.

Institutions holding AMRN in Q2 2026
Institution	Shares	Value	% of portfolio	Change in shares	Action
Sarissa Capital Management LP	1,673,395	$26.7M	15.00%	00.0%	Unchanged
Acadian Asset Management LLC	720,984	$11.5M	0.01%	+84,215+13.2%	Added
Kynam Capital Management, LP	532,982	$8.50M	0.47%	+60,600+12.8%	Added
Morgan Stanley	223,617	$3.56M	0.00%	−69,555−23.7%	Reduced
Waterfront Wealth Inc.	213,949	$3.18M	0.49%	+10,611+5.2%	Added
Brooklands Fund Management Ltd	177,325	$2.74M	2.15%	+161,729+1,037.0%	Added
Eversept Partners, LP	145,296	$2.32M	0.13%	−2,419−1.6%	Reduced
Millennium Management LLC	115,808	$1.85M	0.00%	−184,728−61.5%	Reduced
Two Sigma Investments, LP	100,511	$1.60M	0.00%	−7,031−6.5%	Reduced
Citadel Advisors LLC	95,364	$1.52M	0.00%	+14,789+18.4%	Added

Holders of 5% or more of AMRN

See all 1 holders and filings

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Amarin Corp Plcuk.

Largest holders of AMRN from 13D and 13G filings
Holder	Latest form	Stake	Change	First filed	Latest filing	Filing
Sarissa Capital Management LP	13D/A	6.09%25.7M shares	−1.99 ppfrom 8.08%	Jan 24, 202217 filings	Aug 27, 2026	SEC